Results 131 to 140 of about 1,203 (200)

New preparations in systemic fungal infections [PDF]

Introducere Infecțiile fungice sistemice (invazive) reprezintă o problemă medicală și de sănătate publică majoră în ultimele două decenii. S-a estimat că, la nivel global, 1-1,2 miliarde de persoane sunt afectate de fungi, cu aproximativ 1,5 milioane ...
Bacinschi, Nicolae, Catcov, Carolina, Spînosu, Galina   +2 more
core  

Ann Intern Med [PDF]

Background:Candida auris is an emerging fungal threat that has been spreading in the United States since it was first reported in 2016.Objective:To describe recent changes in the U.S. epidemiology of C auris occurring from 2019 to 2021.Design:Description

core  

State-of-the-Art Review: Managing Vulvovaginal Candidiasis. [PDF]

Clin Infect Dis
Rautemaa-Richardson R, Sobel JD, Stone N, De Seta F, Cassone A, Vieira-Baptista P, Comar M, Warris A, Roselletti E.   +8 more
europepmc   +1 more source

Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial

, 2023
Xiaoyan Liu, Rui Zhang, Rong Li, Qiong Wu, Chao Pan, Xiangqing Yu, Yuhui Liu, Benjie Wang, Shuwen Yu   +8 more
openalex   +1 more source

In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis

, 2021
Jack D. Sobel, Katyna Borroto–Esoda, Nkechi Azie, David Angulo   +3 more
openalex   +1 more source

First Report of Fluconazole-Resistant Candida parapsilosis Harbouring the G458S ERG11p Substitution in a Brazilian Hospital. [PDF]

Mycoses
Gonçalves SS, Maifrede SB, Yäkel E, Peçanha PM, Bessa-Neto FO, Cayô R, Rodrigues AM, Muñoz P, Escribano P, Guinea J.   +9 more
europepmc   +1 more source

Activity of a Novel 1,3-Beta- d -Glucan Synthase Inhibitor, Ibrexafungerp (Formerly SCY-078), against Candida glabrata [PDF]

, 2019
Mahmoud A. Ghannoum, L. Long, N. Isham, Christopher Hager, Rachel Wilson, Katyna Borroto–Esoda, Stephen Barat, D. Angulo   +7 more
openalex   +1 more source

Beyond antifungals: vaginal ceramides as a barrier-restorative strategy for recurrent vulvovaginal candidiasis in Ehlers-Danlos syndrome. [PDF]

Ann Med Surg (Lond)
Amjad M, Fazal M, Talha M, Ali U, Mahato RK.   +4 more
europepmc   +1 more source

The Four Critical Priority Fungi According to the World Health Organization and the Hope for New Therapies: A Focus on Cell Wall Antifungal Targets. [PDF]

J Fungi (Basel)
Marena GD, Carvalho GC, Magalhães MHC, Figueiredo JM, Ramos DH, Nosanchuk JD, Taborda CP.   +6 more
europepmc   +1 more source

The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us. [PDF]

JHLT Open
Lowe A, King ST, Hand J.
europepmc   +1 more source